logo

Summit Therapeutics Inc (SMMT) Stock: A Year of Declines and Increases

DOYU

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Summit Therapeutics Inc’s current trading price is -21.17% away from its 52-week high, while its distance from the 52-week low is 216.54%. The stock’s price range for this time frame has been between $1.30 and $5.22. The trading volume of the company’s shares in the Healthcare reached around 2.28 million for the day, which was evidently higher than the average daily volume of 2.13 million over the last three months.

The stock market performance of Summit Therapeutics Inc has been very steady. Over the last year, the company’s stock hit its highest at $5.22 on 03/05/24, while the lowest price during the same time frame was $1.30, recorded on 04/28/23.

How Financial Performance Impacts Market Capitalization

Summit Therapeutics Inc (SMMT) has experienced a quarterly rise of 55.87% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.89B and boasts a workforce of 105 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.14, with a change in price of +2.35. Similarly, Summit Therapeutics Inc recorded 1,738,374 in trading volume during the last 100 days, posting a change of +133.81%.

How SMMT’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for SMMT stands at 1.37. Similarly, the long-term debt-to-equity ratio is also 1.33.

SMMT Stock Stochastic Average

The raw stochastic average for Summit Therapeutics Inc over the last 50 days is presently at 58.92%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 38.61%. Further, the company’s Stochastic %K and %D values for the last 20 days were 59.72% and 62.69%, respectively.

SMMT Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a gain of 57.66%.However, over the last six months, we can see a weaker performance of 120.05%. Over the last 30 days, the price of SMMT has leaped by -11.88%. And in the last five days, it has fallen by -4.30%.